Retraction
Recent articles
The Transmitter’s favorite features of 2024
Our chosen stories include tales about research misconduct in the lab, a neuroscientist working at the end of the world, and the passing of neuroanatomy’s “great-grandfather,” Harvey Karten.

The Transmitter’s favorite features of 2024
Our chosen stories include tales about research misconduct in the lab, a neuroscientist working at the end of the world, and the passing of neuroanatomy’s “great-grandfather,” Harvey Karten.
Former Columbia University psychiatrist committed research misconduct, says federal watchdog
Bret Rutherford, whose research was halted following a suicide in a clinical trial, falsely reported participant eligibility, according to the U.S. Office of Research Integrity.

Former Columbia University psychiatrist committed research misconduct, says federal watchdog
Bret Rutherford, whose research was halted following a suicide in a clinical trial, falsely reported participant eligibility, according to the U.S. Office of Research Integrity.
A scientific fraud. An investigation. A lab in recovery.
Science is built on trust. What happens when someone destroys it?

A scientific fraud. An investigation. A lab in recovery.
Science is built on trust. What happens when someone destroys it?
Second paper from lab of Nobel Prize winner to be retracted
The paper was corrected in May, but comments on PubPeer spurred further analysis.

Second paper from lab of Nobel Prize winner to be retracted
The paper was corrected in May, but comments on PubPeer spurred further analysis.
Task swap prompts data do-over for autism auditory perception study
The investigators retracted their paper after other researchers pointed out the error; the original team plans to redo the experiment, according to one author.

Task swap prompts data do-over for autism auditory perception study
The investigators retracted their paper after other researchers pointed out the error; the original team plans to redo the experiment, according to one author.
Faked results lead to retraction of high-profile cancer neuroscience study
An investigation found that the experiments required more animals than the scientists had purchased.

Faked results lead to retraction of high-profile cancer neuroscience study
An investigation found that the experiments required more animals than the scientists had purchased.
Anti-vax blogger retracts critique of study that debunked vaccination-autism link
The commentary contained misguided criticisms of the study’s statistical methods, the lead investigator says.

Anti-vax blogger retracts critique of study that debunked vaccination-autism link
The commentary contained misguided criticisms of the study’s statistical methods, the lead investigator says.
FDA describes ‘objectionable conditions’ at New York State Psychiatric Institute
The facility’s institutional review board failed to report a 2021 incident and “serious and ongoing noncompliance” by a principal investigator, according to a letter released by the federal agency this week.

FDA describes ‘objectionable conditions’ at New York State Psychiatric Institute
The facility’s institutional review board failed to report a 2021 incident and “serious and ongoing noncompliance” by a principal investigator, according to a letter released by the federal agency this week.
Nobel Prize winner Thomas Südhof retracts study
The retraction follows an editorial expression of concern that the journal applied to the paper in October, seven months after it was published in the Proceedings of the National Academy of Sciences.

Nobel Prize winner Thomas Südhof retracts study
The retraction follows an editorial expression of concern that the journal applied to the paper in October, seven months after it was published in the Proceedings of the National Academy of Sciences.
Autism journal retracts speech-recognition paper, pauses special issue
The journal’s publisher flagged problems in 11 papers that were part of a special issue on assistive technology in special education.

Autism journal retracts speech-recognition paper, pauses special issue
The journal’s publisher flagged problems in 11 papers that were part of a special issue on assistive technology in special education.
Explore more from The Transmitter
Reporter’s notebook: Highlights from INSAR 2025
The annual meeting brought autism researchers, advocates and clinicians to Seattle to discuss the latest research, including attempts to define subgroups, a potential new CHD8 macaque model and life expectancy gaps.

Reporter’s notebook: Highlights from INSAR 2025
The annual meeting brought autism researchers, advocates and clinicians to Seattle to discuss the latest research, including attempts to define subgroups, a potential new CHD8 macaque model and life expectancy gaps.
NIDA shutters diversity fellowship program, axes active awards
It’s unclear if the cancellation at the U.S. National Institute on Drug Abuse extends to the fellowships awarded by other institutes within the National Institutes of Health.

NIDA shutters diversity fellowship program, axes active awards
It’s unclear if the cancellation at the U.S. National Institute on Drug Abuse extends to the fellowships awarded by other institutes within the National Institutes of Health.
‘We still exist’: How four neuroscience advocacy groups are navigating federal DEI funding cuts
Trainees from underrepresented backgrounds are losing pillars of support in the current funding climate. Grassroots mentorship organizations are stepping in to continue championing early-career researchers.

‘We still exist’: How four neuroscience advocacy groups are navigating federal DEI funding cuts
Trainees from underrepresented backgrounds are losing pillars of support in the current funding climate. Grassroots mentorship organizations are stepping in to continue championing early-career researchers.